Kenvue Inc.

KVUE 10-Q · Q3 2025
API behind this page

KVUE Q3 2025 request

Playground key active
Request URL /api/financials?ticker=KVUE&year=2025&quarter=3
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q3 2025 Q3 2024 YoY
Revenue 3,764 3,899 -3.5%
Show Business Segments breakouts
Essential Health 1,162 1,202 -3.3%
Self Care 1,564 1,625 -3.8%
Skin Health and Beauty 1,038 1,072 -3.2%
Cost of Revenue 1,538 1,617 -4.9%
Show Counterparty Name breakouts
Johnson & Johnson 40 44 -9.1%
Show Restructuring Plan breakouts
2024 Multi-Year Restructuring Initiative 8 4 +100.0%
Gross Profit 2,226 2,282 -2.5%
Selling, General & Administrative 1,512 1,590 -4.9%
Show Restructuring Plan breakouts
2024 Multi-Year Restructuring Initiative 5 3 +66.7%
Restructuring Charges 84 31 +171.0%
Show Restructuring Plan breakouts
2024 Multi-Year Restructuring Initiative 84 31 +171.0%
Other Operating Income Expense Net 1 7 -85.7%
Operating Income 629 654 -3.8%
Non-Operating Income (Expense) 10 -19 +152.6%
Interest Income Expense Nonoperating Net 93 96 -3.1%
Income Before Taxes 526 577 -8.8%
Income Tax Expense (Benefit) 128 194 -34.0%
Net Income 398 383 +3.9%
Show Equity Components breakouts
Retained Earnings 398 383 +3.9%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 9 6 +50.0%
Show Related Party Transaction breakouts
Net Economic Benefit Arrangements · Parent 4 7 -42.9%
EPS (Basic) 0.21 0.2 +5.0%
EPS (Diluted) 0.21 0.2 +5.0%
Wtd Avg Shares (Basic) 1,918 1,915 +0.2%
Wtd Avg Shares (Diluted) 1,923 1,924 -0.1%
Research & Development 94 97 -3.1%
Other Non-Operating Income (Expense) -10 1 -1100.0%
Comprehensive Income 340 859 -60.4%
Other Comprehensive Income -58 476 -112.2%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment 7 -7 +200.0%
Accumulated Other Comprehensive Income -58 476 -112.2%
Accumulated Translation Adjustment -65 473 -113.7%

Balance Sheet

Balance Sheet
Metric Q3 2025 Q3 2024 YoY
Current Assets
Cash & Cash Equivalents 1,139 — —
Accounts Receivable 2,416 2,394 +0.9%
Inventory 1,794 1,820 -1.4%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 28 25 +12.0%
Prepaid Expenses & Other Current Assets 531 460 +15.4%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 5 3 +66.7%
Show Counterparty Name breakouts
Johnson & Johnson 65 103 -36.9%
Other Assets Current 152 210 -27.6%
Total Current Assets 6,032 5,941 +1.5%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 238 195 +22.1%
Non-Current Assets
Property, Plant & Equipment 2,092 1,776 +17.8%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 3 2 +50.0%
Goodwill 9,441 9,297 +1.5%
Show Business Segments breakouts
Essential Health 1,674 1,656 +1.1%
Self Care 5,479 5,325 +2.9%
Skin Health and Beauty 2,288 2,316 -1.2%
Deferred Tax Assets 237 — —
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 5 — —
Other Non-Current Assets 730 — —
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 5 — —
Show Counterparty Name breakouts
Johnson & Johnson 90 — —
Total Assets 27,248 26,925 +1.2%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 251 200 +25.5%
Intangible Assets 3,850 3,893 -1.1%
Show Finite Lived Intangible Assets By Major Class breakouts
Customer Relationships 871 910 -4.3%
Other Intangible Assets 576 607 -5.1%
Patents and trademarks 2,403 2,376 +1.1%
Other Assets
Intangible Assets Net Excluding Goodwill 8,716 8,887 -1.9%
Show Indefinite Lived Intangible Assets By Major Class breakouts
Other Intangible Assets 62 56 +10.7%
Trademarks 4,804 4,938 -2.7%
Current Liabilities
Debt Current 1,913 1,648 +16.1%
Accounts Payable 2,445 — —
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 4 — —
Show Related Party Transaction breakouts
Net Economic Benefit Arrangements · Parent 25 — —
Accrued Liabilities 958 1,164 -17.7%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 11 11 0.0%
Accrued Rebates Returns And Promotions Current 737 697 +5.7%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 19 15 +26.7%
Accrued Income Taxes Current 103 163 -36.8%
Total Current Liabilities 6,156 5,946 +3.5%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 34 27 +25.9%
Commercial Paper 1,160 890 +30.3%
Current Portion of Long-Term Debt -750 -750 0.0%
Non-Current Liabilities
Deferred Tax Liabilities 2,425 2,378 +2.0%
Employee Related Liabilities Current And Noncurrent 373 362 +3.0%
Other Non-Current Liabilities 600 — —
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 3 — —
Show Counterparty Name breakouts
Johnson & Johnson 155 — —
Total Liabilities 16,614 16,281 +2.0%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 37 27 +37.0%
Operating Lease Liabilities 98 — —
Accrued Income Taxes Noncurrent 213 184 +15.8%
Other Liabilities
Long Term Debt And Lease Obligation Excluding Current Maturities 7,060 7,053 +0.1%
Stockholders' Equity
Common Stock 19 19 0.0%
Additional Paid-In Capital 16,320 16,098 +1.4%
Treasury Stock Common Value -439 -121 -262.8%
Retained Earnings -136 7 -2042.9%
Accumulated Other Comprehensive Income -5,130 -5,359 +4.3%
Total Stockholders' Equity 10,634 10,644 -0.1%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -131 -168 +22.0%
Accumulated Other Comprehensive Income -5,130 -5,359 +4.3%
Accumulated Translation Adjustment -5,040 -5,216 +3.4%
Additional Paid In Capital 16,320 16,098 +1.4%
Common Stock 19 19 0.0%
Gain on Derivatives and Hedges 41 25 +64.0%
Retained Earnings -136 7 -2042.9%
Treasury Stock Common -439 -121 -262.8%
Total Liabilities & Equity 27,248 26,925 +1.2%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q3 2025 YTD Q3 2024 YoY
Operating Activities
Depreciation & Amortization 419 472 -11.2%
Show Business Segments breakouts
Essential Health 171 174 -1.7%
Self Care 154 155 -0.6%
Skin Health and Beauty 94 143 -34.3%
Stock-Based Compensation 106 200 -47.0%
Deferred Income Taxes -11 -245 +95.5%
Other Non-Cash Items 54 36 +50.0%
Change in Accounts Receivable -147 -343 +57.1%
Change in Inventory -144 13 -1207.7%
Increase Decrease In Other Operating Assets 147 29 +406.9%
Increase Decrease In Accounts Payable And Accrued Liabilities -89 -573 +84.5%
Increase Decrease In Employee Related Liabilities 17 5 +240.0%
Increase Decrease In Accrued Taxes Payable -80 9 -988.9%
Increase Decrease In Other Operating Liabilities -69 27 -355.6%
Net Cash from Operations 1,343 976 +37.6%
Investing Activities
Capital Expenditures -365 -302 -20.9%
Other Investing Activities 4 9 -55.6%
Net Cash from Investing -361 -293 -23.2%
Financing Activities
Proceeds From Repayments Of Commercial Paper 324 258 +25.6%
Proceeds From Issuance Of Unsecured Debt 746 — —
Repayments Of Senior Debt -750 — —
Payments Of Dividends -1,183 -1,159 -2.1%
Share Repurchases -197 -114 -72.8%
Proceeds From Payments For Other Financing Activities 92 37 +148.6%
Net Cash from Financing -968 -978 +1.0%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 55 -30 +283.3%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1,139 1,057 +7.8%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 126 107 +17.8%
Net Change in Cash 69 -325 +121.2%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key